Integra LifeSciences Holdings (IART) — Cash Flow Reinvestment Rate
Integra LifeSciences Holdings (IART) has a Cash Flow Reinvestment Rate of 0.75x as of September 2025, reinvesting $30.74 Million (capex $15.16 Million plus investments $-15.59 Million) from operating cash flow of $40.91 Million. Explore how much does Integra LifeSciences Holdings reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Integra LifeSciences Holdings Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Integra LifeSciences Holdings across 25 annual periods. Also explore Integra LifeSciences Holdings total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Integra LifeSciences Holdings (1999–2024)
Year-by-year capital reinvestment analysis for Integra LifeSciences Holdings. For live market cap and broader valuation context, see IART market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.83x | $495.23 Million | $129.38 Million | $104.42 Million | ▲ +232.6% |
| 2023 | 1.15x | $161.04 Million | $139.96 Million | $66.86 Million | ▲ +485.3% |
| 2022 | 0.20x | $51.99 Million | $264.47 Million | $47.09 Million | ▲ +27.5% |
| 2021 | 0.15x | $48.16 Million | $312.43 Million | $48.08 Million | ▼ -56.2% |
| 2020 | 0.35x | $71.73 Million | $203.83 Million | $63.89 Million | ▼ -40.5% |
| 2019 | 0.59x | $136.87 Million | $231.43 Million | $134.53 Million | ▲ +50.1% |
| 2018 | 0.39x | $78.65 Million | $199.68 Million | $77.74 Million | ▼ -26.0% |
| 2017 | 0.53x | $60.94 Million | $114.54 Million | $43.50 Million | ▼ -31.2% |
| 2016 | 0.77x | $89.95 Million | $116.41 Million | $47.33 Million | ▲ +45.0% |
| 2015 | 0.53x | $50.36 Million | $94.48 Million | $33.41 Million | ▼ -28.6% |
| 2014 | 0.75x | $59.35 Million | $79.46 Million | $42.40 Million | ▼ -16.9% |
| 2013 | 0.90x | $47.85 Million | $53.27 Million | $47.85 Million | ▼ -26.7% |
| 2012 | 1.23x | $72.00 Million | $58.72 Million | $69.03 Million | ▲ +232.9% |
| 2011 | 0.37x | $38.42 Million | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $37.14 Million | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $27.57 Million | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $13.40 Million | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $22.57 Million | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $11.52 Million | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $8.05 Million | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $8.51 Million | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $3.84 Million | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $2.25 Million | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $2.86 Million | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $17.30 Million | $2.50 Million | $17.30 Million | — |